Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SH-201 by Shorla Oncology for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
SH-201 is under clinical development by Shorla Oncology and currently in Pre-Registration for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)....
SH-201 by Shorla Oncology for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia): Likelihood of Approval
SH-201 is under clinical development by Shorla Oncology and currently in Pre-Registration for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)....
SH-201 by Shorla Oncology for Myelodysplastic Syndrome: Likelihood of Approval
SH-201 is under clinical development by Shorla Oncology and currently in Pre-Registration for Myelodysplastic Syndrome. According to GlobalData, Pre-Registration drugs...
SH-201 by Shorla Oncology for Gastrointestinal Tumor: Likelihood of Approval
SH-201 is under clinical development by Shorla Oncology and currently in Pre-Registration for Gastrointestinal Tumor. According to GlobalData, Pre-Registration drugs...